These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38478102)
21. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. Izawa JI; Perrotte P; Greene GF; Scott S; Levy L; McGuire E; Madsen L; von Eschenbach AC; Pisters LL J Urol; 2001 Mar; 165(3):867-70. PubMed ID: 11176488 [TBL] [Abstract][Full Text] [Related]
22. [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results]. Gevorgyan A; Hétet JF; Robert M; Duchattelle-Dussaule V; Corno L; Boulay I; Baumert H Prog Urol; 2018 Apr; 28(5):291-301. PubMed ID: 29551263 [TBL] [Abstract][Full Text] [Related]
23. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS Perm J; 2019; 23():. PubMed ID: 31050644 [TBL] [Abstract][Full Text] [Related]
24. Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer. Tan WP; ElShafei A; Aminsharifi A; Khalifa AO; Polascik TJ Clin Genitourin Cancer; 2020 Jun; 18(3):e260-e265. PubMed ID: 31892490 [TBL] [Abstract][Full Text] [Related]
25. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze. Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413 [TBL] [Abstract][Full Text] [Related]
26. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508 [TBL] [Abstract][Full Text] [Related]
27. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924 [TBL] [Abstract][Full Text] [Related]
29. Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survival. Maoui M; Gonindard-Melodelima C; Chapet O; Colombel M; Ruffion A; Crouzet S; Rouvière O Diagn Interv Imaging; 2021 Feb; 102(2):93-100. PubMed ID: 32534903 [TBL] [Abstract][Full Text] [Related]
30. PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. Ko EC; Stone NN; Stock RG Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):600-7. PubMed ID: 21985944 [TBL] [Abstract][Full Text] [Related]
31. The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. Lee EE; Singh T; Hu C; Han M; Deville CJ; Halthore A; Greco S; Tran P; DeWeese T; Song DY Prostate; 2023 Feb; 83(2):190-197. PubMed ID: 36316967 [TBL] [Abstract][Full Text] [Related]
32. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229 [TBL] [Abstract][Full Text] [Related]
33. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
34. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777 [TBL] [Abstract][Full Text] [Related]
35. Predictive value of prostate specific antigen nadir after salvage cryotherapy. Greene GF; Pisters LL; Scott SM; Von Eschenbach AC J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611 [TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients. Cetin IA; Akay SU; Sengoz M BMC Urol; 2022 Nov; 22(1):182. PubMed ID: 36376849 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959 [TBL] [Abstract][Full Text] [Related]
38. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence. Fukuda I; Aoki M; Kimura T; Ikeda K Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540 [TBL] [Abstract][Full Text] [Related]
39. Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy. Jackson WC; Johnson SB; Foster B; Foster C; Li D; Song Y; Vainshtein J; Zhou J; Hamstra DA; Feng FY Pract Radiat Oncol; 2014; 4(2):99-107. PubMed ID: 24890350 [TBL] [Abstract][Full Text] [Related]
40. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]